Science Explorer Back to mapMap
Discussion
Researcher · Centre Léon Bérard · France

Amine Belhabri

Amine Belhabri publishes mostly in Hematology, Oncology and Genetics, on topics such as Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments and Acute Lymphoblastic Leukemia research.

ORCID 0000-0003-0870-4830 OpenAlex
World rank
#1,448,871
of 7,710,434 ranked researchers
Rank in France
#65,297
of 324,115
Works
126
Citations
1.3k
Citations per work
10.3
h-index
20
i10-index 30Top 24% in Hematology
Amine Belhabri

What does Amine Belhabri research?

Amine Belhabri's work is mostly in Medicine (70%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 88 works · 69.9% of their workMedicine: 88 works · 69.9% of their workHematology: 44 works · 35.3% of their workOncology: 17 works · 13.1% of their workGenetics: 13 works · 10.2% of their workPublic Health, Environmental and Occupational Health: 8 works · 6.0% of their workPathology and Forensic Medicine: 7 works · 5.3% of their workEverything else: 28 works · 22.3% of their workLife Sciences: 10 works · 7.8% of their workBiochemistry, Genetics and Molecular Biology: 10 works · 7.8% of their workMolecular Biology: 10 works · 7.8% of their workTHEIR WORKAmine Belhabri126works
Life Sciences8%Health Sciences70%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine8869.9%
  2. Everything else2822.3%
    1. Biochemistry, Genetics and Molecular Biology107.8%
  1. 1Hematology35% of their works
  2. 2Oncology13% of their works
  3. 3Genetics10% of their works
  4. 4Molecular Biology8% of their works
  5. 5Public Health, Environmental and Occupational Health6% of their works
  6. 6Pathology and Forensic Medicine5% of their works

Research topics

Which keywords describe Amine Belhabri's research?

The keywords of their largest research topics: Prognostic Factors, Hematopoietic Stem Cells, Acute Myeloid Leukemia, AML, Minimal Residual Disease, BCR-ABL, Imatinib and Rituximab.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors783 topics
  2. Hematopoietic Stem Cells632 topics
  3. AML511 topic
  4. Acute Myeloid Leukemia511 topic
  5. Minimal Residual Disease272 topics
  6. BCR-ABL261 topic
  7. Imatinib261 topic
  8. Rituximab262 topics
  9. Acute Lymphoblastic Leukemia161 topic
  10. Childhood Cancer161 topic
  11. Classification151 topic
  12. Lymphoma151 topic
  13. JAK2 Mutation131 topic
  14. Myelofibrosis131 topic
  15. Bone Marrow Niche121 topic
  16. Graft-versus-Host Disease121 topic
  17. Chronic Lymphocytic Leukemia111 topic
  18. Diagnosis Criteria111 topic
  19. Genomic Aberrations111 topic
  20. International Myeloma Working Group111 topic

Where does Amine Belhabri work?

Amine Belhabri's main affiliation in the publication record is Centre Léon Bérard, France.

How many publications and citations does Amine Belhabri have?

OpenAlex counts 126 works and 1,295 citations for Amine Belhabri, an h-index of 20, ranking #1,448,871 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Amine Belhabri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.